GBE has made further progress on the path to commerciality by achieving one of the first technical milestones for its joint venture with Cristal Union. It has achieved isobutene production on the basis of sucrose as a feedstock. This progresses it further on the route to commercial licensing, which should support confidence in the company’s execution. Our DCF based valuation range is €35-63.
27 Jul 2015
On the road to commerciality
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
On the road to commerciality
GBE has made further progress on the path to commerciality by achieving one of the first technical milestones for its joint venture with Cristal Union. It has achieved isobutene production on the basis of sucrose as a feedstock. This progresses it further on the route to commercial licensing, which should support confidence in the company’s execution. Our DCF based valuation range is €35-63.